高血糖症加剧缺血性中风并不是通过增加过氧化的产生
Daria A Kotova1, Aleksandra D Ivanova1, Matvei S Pochechuev2
1M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.
Free radical biology & medicine
|August 5, 2023
概括
糖尿病患者的高血糖会通过改变线粒体功能,而不是通过增加缺血核心中的过氧化 (H2O2) 来恶化中风的结果. 这项研究揭示了对高血糖性中风病原体的新见解.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理生理学 病理生理学
背景情况:
- 糖尿病是缺血性中风的主要危险因素.
- 与糖尿病相关的高血糖会加剧大脑损伤和中风的严重程度.
- 将高血糖与缺血性损伤联系在一起的精确生化机制尚不清楚.
研究的目的:
- 在高血糖和正常葡萄糖条件下的缺血性中风期间,研究神经元线粒体中过氧化 (H2O2) 的实时动态.
- 在缺血损伤的背景下,阐明高血糖对线粒体生化过程的影响.
- 为了探索血糖升高在中风的发病过程中的作用.
主要方法:
- 使用敏感的HyPer7生物传感器和光纤接口技术进行实时H2O2测量.
- 对培养的神经元进行了体外研究,对大鼠大脑组织进行了体内研究.
- 采用拉曼显微镜来分析醒着小鼠的线粒体电子运输链活动.
主要成果:
- 高血糖症并没有改变缺血核心中的H2O2生成,但显著恶化了中风的发病性.
- 血糖水平升高被证明会增加线粒体电子运输链中减少的细胞染色体的相对数量.
- 这表明高血糖影响神经元线粒体超出了缺血事件期间的H2O2生产.
结论:
- 高血糖症通过影响线粒体电子运输链功能而加剧缺血性中风的后果,而不是通过缺血核心中的H2O2增加氧化应激.
- 这些发现提供了对糖尿病相关中风严重程度背后的生化途径的新见解.
- 了解这些机制可能会为糖尿病中风患者的治疗策略提供信息.
相关概念视频
Hypoglycemia and Glucagon
297
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
297
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Overview of Carbohydrate Metabolism
1.2K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.2K
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
206
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
206
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K


